{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:33Z","timestamp":1786119393847,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1097\/sap.0b013e3181a13dbf","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T00:38:53Z","timestamp":1263861533000},"page":"229-232","source":"Crossref","is-referenced-by-count":6,"title":["Metachronous Primary Melanoma and Lymphoma"],"prefix":"10.1097","volume":"64","author":[{"given":"Bryan C.","family":"McIntosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ariyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Esche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Zelterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210202","first-page":"1","article-title":"Metachronous multiple malignancies in 5876 cancer patients.","volume":"34","author":"Peller","year":"1941","journal-title":"Am J Hygiene"},{"key":"R2-26-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/1097-0142(196103\/04)14:2<221::AID-CNCR2820140202>3.0.CO;2-6","article-title":"Multiple primary malignant neoplasms.","volume":"14","author":"Moertel","year":"1961","journal-title":"Cancer"},{"key":"R3-26-20210202","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1097\/00006534-199511000-00023","article-title":"Multiple primary melanomas: data and significance.","volume":"96","author":"Ariyan","year":"1995","journal-title":"Plast Reconstr Surg"},{"key":"R4-26-20210202","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","article-title":"Risk of second primary malignancies in patients with cutaneous melanoma.","volume":"145","author":"Schmid-Wendtner","year":"2001","journal-title":"Br J Dermatol"},{"key":"R5-26-20210202","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/ijc.2910610606","article-title":"Risk of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943\u20131989.","volume":"61","author":"Swerdlow","year":"1995","journal-title":"Int J Cancer"},{"key":"R6-26-20210202","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/cncr.11116","article-title":"A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors.","volume":"97","author":"Goggins","year":"2003","journal-title":"Cancer"},{"key":"R7-26-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000068452","article-title":"Significant risk of second melanoma in patients with a history of melanoma but no further predisposing factors.","volume":"206","author":"Nashan","year":"2003","journal-title":"Dermatology"},{"key":"R8-26-20210202","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1001\/archsurg.1995.01430100034007","article-title":"The association between melanoma, lymphoma, and other primary neoplasms.","volume":"130","author":"Riou","year":"1995","journal-title":"Arch Surg"},{"key":"R9-26-20210202","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1097-0142(20010215)91:4<874::AID-CNCR1076>3.0.CO;2-O","article-title":"Evidence for an association between cutaneous melanoma and non-Hodgkin's lymphoma.","volume":"91","author":"Goggins","year":"2001","journal-title":"Cancer"},{"key":"R10-26-20210202","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1002\/1097-0142(19910401)67:7<2002::AID-CNCR2820670729>3.0.CO;2-E","article-title":"Second cancers following non-Hodgkin's lymphoma.","volume":"67","author":"Travis","year":"1991","journal-title":"Cancer"},{"key":"R11-26-20210202","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1054\/bjoc.2001.1998","article-title":"Second primary neoplasms among 53159 haematolymphoproliferative malignancy patients in Sweden, 1958\u20131996: a search for common mechanisms.","volume":"85","author":"Dong","year":"2001","journal-title":"Br J Cancer"},{"key":"R12-26-20210202","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.310.6993.1491","article-title":"Evidence of an association between non-Hodgkin's lymphoma and skin cancer.","volume":"310","author":"Adami","year":"1995","journal-title":"BMJ"},{"key":"R13-26-20210202","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.bjc.6602654","article-title":"Second primary cancers among 109000 cases of non-Hodgkin's lymphoma.","volume":"93","author":"Brennan","year":"2005","journal-title":"Br J Cancer"},{"key":"R14-26-20210202","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00008469-200402000-00006","article-title":"Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.","volume":"1","author":"Crocetti","year":"2004","journal-title":"Eur J Cancer Prev"},{"key":"R15-26-20210202","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1067\/mjd.2001.118353","article-title":"A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma.","volume":"46","author":"Tsao","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"R16-26-20210202","article-title":"SEER Cancer Statistics Review 1975\u20132001.","author":"Ries","year":"2004"},{"key":"R17-26-20210202","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/annonc\/mdf289","article-title":"Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time.","volume":"13","author":"Abrahamsen","year":"2002","journal-title":"Ann Oncol"},{"key":"R18-26-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/10428190500464187","article-title":"Association between lymphoma and melanoma: report of a single-center series of eight patients and a review of the literature.","volume":"47","author":"Loriot","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"R19-26-20210202","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1056\/NEJM198801143180203","article-title":"Risk of second cancers after treatment for Hodgkin's disease.","volume":"318","author":"Tucker","year":"1988","journal-title":"N Engl J Med"},{"key":"R20-26-20210202","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00008390-200110000-00012","article-title":"Synchronous high-risk melanoma and lymphoid neoplasia.","volume":"11","author":"Cahill","year":"2001","journal-title":"Melanoma Res"},{"key":"R21-26-20210202","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdi080","article-title":"An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.","volume":"16","author":"Lens","year":"2005","journal-title":"Ann Oncol"},{"key":"R22-26-20210202","first-page":"108","article-title":"Expression of bcl-2 oncogene protein in malignant lymphomas, including Hodgkin's disease and non-Hodgkin's lymphomas of T-cell phenotype.","volume":"1","author":"Said","year":"1993","journal-title":"Appl Immunohistochem"},{"key":"R23-26-20210202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/ajcp\/102.4.464","article-title":"Bcl-2 oncogene is preferentially expressed in Reed-Sternberg cells in Hodgkin's disease of the nodular sclerosis subtype.","volume":"102","author":"Lones","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"R24-26-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0748-7983(96)90176-6","article-title":"Bcl-2 expression in malignant melanoma and its prognostic significance.","volume":"22","author":"Grover","year":"1996","journal-title":"Eur J Surg Oncol"},{"key":"R25-26-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000372-199502000-00002","article-title":"Bcl-2 protein in cutaneous malignant melanoma and benign melanocytic nevi.","volume":"17","author":"Cerroni","year":"1995","journal-title":"Am J Dermatopathol"},{"key":"R26-26-20210202","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2559.1999.0747a.x","article-title":"Coexistence of malignant melanoma, Hodgkin's disease and follicular lymphoma with expression of the B-cell leukaemia\/lymphoma (bcl-2) oncogene.","volume":"35","author":"Castella","year":"1999","journal-title":"Histopathology"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SAP.0b013e3181a13dbf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:12:42Z","timestamp":1786039962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000637-201002000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0b013e3181a13dbf","relation":{},"ISSN":["0148-7043"],"issn-type":[{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}